More Medical Developments International Limited news
Medical Developments International LimitedASX: MVP

S&P DJI Announces June 2020 Quarterly Rebalance

Jun 11, 2020 at 10:36 PM EDT · Issued by Medical Developments International Limited

Filed with ASX · Jun 11, 2020 at 10:36 PM EDT · 10 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-june-2020-quarterly-rebalance-40

Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19↗

Medical Developments International Limited on 6ix

Earlier from Medical Developments International

  • Penthrox approved in HungaryMay 25, 2020
  • Penthrox approved - Netherlands and Bosnia and HerzegovinaMay 4, 2020
  • Penthrox is approved in ThailandApr 27, 2020
  • COVID-19 Impact on MVPMar 17, 2020
  • MVP announces leadership changeMar 4, 2020

Later from Medical Developments International

  • Medical Developments to take control of EU marketsAug 18, 2020
  • Appointment of Non-Executive Director - Gordon NaylorOct 14, 2020
  • Appointment of CEO - Brent MacGregorOct 14, 2020
  • Chairmans and CEOs Address to ShareholdersOct 27, 2020
  • MVP and MundiPharma cease Australian licensing agreementOct 30, 2020
All Medical Developments International news releases↗

Follow Medical Developments International into a list and get an email when it puts out news.

Follow Medical Developments International
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer